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The Influence of Dressings on Venous Ulcer Hea l ing- -A  
Randomised Trial 
M. C. Stacey*, A. G. Jopp-Mckay, P. Rashid, S. E. Hoskin and P. J. Thompson 
University Department of Surgery, Fremantle Hospital, Western Australia 
Objective: To assess the effect of different dressings on venous ulcer healing. 
Design: A randomised clinical trial. 
Materials: Patients were randomised to treatment with one of three dressings: a zinc oxide impregnated bandage, a zinc 
oxide impregnated stockingette, or an alginate dressing. All patients were treated as outpatients and had compression 
bandaging with two minimal stretch bandages (Elastocrepe) and a stockingette (Tubigrip) to keep the bandages in place. 
Methods: One hundred and thirteen patients (133 ulcerated limbs) with chronic ulceration of the leg due to venous disease 
alone, and attending Fremantle Hospital Leg Ulcer Clinic, Western Australia were entered into the study. Healing was 
measured as complete healing of the ulcerated limb or failure of the limb to heal within 9 months. 
Results: There was no significant difference between the three groups in ulcer size, duration, and other parameters 
compared. Healing was affected significantly by ulcer size and which leg was ulcerated. There was significantly faster 
healing with the paste bandage. 
Conclusion: The use of a paste bandage significantly improved the healing of chronic venous ulcers when used in 
combination with compression bandaging, and compared to an alginate dressing and a zinc oxide impregnated 
stockingette. 
Key Words: Randomised controlled trial; Venous ulcer; Wound dressing. 
Introduction 
Chronic venous ulceration is a difficult clinical prob- 
lem that consumes a large amount of resources. These 
resources include medical and nursing time as well as 
cleansing solutions, other topical applications, dress- 
ing products, bandages and elastic stockings. The 
treatment ofthese patients i  spread across many areas 
of health care ~ and the costs have been estimated at 
between 1.1% and 1.3% of the total health care budget 
in several European communities. 2 
The treatments u ed for leg ulcers today differ little 
from those that have been used for centuries. In spite 
of the large amounts of money expended on treating 
these ulcers, there has been little research that actively 
reflects the effectiveness of the treatments. Many 
published studies are unable to provide firm conclu- 
sions on methods for improving venous ulcer healing. 
The reasons that most frequently accounts for this are 
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treating ulcerated limbs with more than one aetiol- 
ogy, 3'4 using different bandaging regimens in the 
different dressing roups that are compared, 5'6 using 
inadequate measures of healing such as reduction in 
size at a given time interval, 7-1° using inadequate 
sample sizes 11 or having no control group. ~2 The only 
effective measure of treating outpatients with dress- 
ings is total healing of the ulcerated limb. 13A4 These 
deficiencies have been part of the reason for the lack of 
new effective methods for improving the healing of 
chronic venous ulcers. 
In our Leg Ulcer Clinic the standard method of 
dressing leg ulcers has been to employ a paste 
bandage (Viscopaste, Smith & Nephew) and minimal 
stretch bandages (Elastocrepe, Smith & Nephew). The 
paste bandage has the disadvantage of being an 
expensive dressing and being time consuming to 
apply. In this study we compared three different 
dressings under the same bandages, to see if we could 
improve the time to healing of the ulcerated limbs 
using dressings that were easier to apply. In addition 
we assessed the specific factors that influenced the 
time to healing. 
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Methods 
This was a prospective randomised trial. The dress- 
ings employed were a zinc oxide impregnated paste 
bandage (Viscopaste, Smith & Nephew) a zinc oxide 
impregnated stockingette (Acoband, Auspharm), and 
a calcium alginate fibre dressing (Kaltostat, Faulding 
Pharmaceuticals). The zinc oxide stockingette was 
chosen because it contained zinc but did not have the 
same non-stretch bandage characteristics present in 
the paste bandage and would allow a comparison 
with that dressing. Kaltostat was chosen because of its 
ease of application and also it has been considered to 
be an "interactive" dressing that might directly influ- 
ence wound healing. 15 
For this study only patients with proven venous 
ulceration were considered. A full history of ulceration 
was taken and a careful examination was performed. 
The patient characteristics recorded were: age, sex, 
duration of the current ulcer, number of ulcer episodes 
on the affected limb, the time since the first ulcer on 
the affected limb, the longest ime with an unhealed 
ulcer, the side of the ulcerated limb and the total area 
of ulceration on the affected limb. Investigations 
performed to determine the aetiology of ulceration 
were: a full blood picture and ESR, urea and electro- 
lytes, liver function tests, blood sugar, rheumatoid 
factors, resting ankle brachial Doppler arterial pres- 
sure index (normal > 0.90), and venous refilling on 
photoplethysmography (PPG) (< 25 s is abnormal in 
our laboratory16). The venous abnormality was 
defined as superficial if the refilling time on PPG 
returned to normal with an above-knee or below-knee 
tourniquet. If the refilling time did not return to 
normal with a tourniquet, the venous abnormality 
was considered to be due to either deep venous 
disease or communicating vein incompetence. 17 
For the purposes of this study only ulcers with a 
minimum diameter of 0.Scm and a maximum diame- 
ter of 10cm, in the longest diameter, were included. 
Patients with evidence of diabetes, rheumatoid arthri- 
tis, arterial disease or any other possible contributing 
factor to the ulceration were excluded. Patients who 
had evidence of cellulitis at the time of randomisation 
were also excluded from this study. 
Treatment was performed on an outpatient basis in 
a specialised Leg Ulcer Clinic. The leg and foot were 
washed in a soap-water bath and any loose debris was 
debrided from the surface of the ulcer. Viscopaste was 
applied in a spiral fashion from the base of the toes to 
just below the knee, Acoband was applied from the 
base of the toes to just below the knee, and Kaltostat 
was applied only over the ulcer itself and was 
moistened with saline at the time of application. Over 
each of these dressings two Elastocrepe bandages 
(Smith & Nephew) were applied from the base of the 
toes to just below the knee and a Tubigrip stockingette 
(Seton) was placed over the bandages to keep them in 
place. The dressings were changed once weekly. 
However, in the very early stages, if there was 
excessive xudate, the dressings were changed twice 
and, on some occasions, three times a week. Once the 
exudate had subsided they reverted to weekly 
dressings. 
Patients were considered withdrawals from the 
study if the dressings had to be discontinued for 
reasons other than failure of the ulcer to heal. These 
causes of withdrawal included allergy to the dress- 
ings, excessive pain with the application of the 
dressing, the development of cellulitis in the leg, or if 
the patient had some medical or personal reason 
which prevented them from continuing with the 
dressings. Data up to the point of withdrawal were 
included in the final analysis. 
Dressings were continued for 9 months or until the 
limbs had healed. Treatment was considered to have 
failed if the limb remained unhealed at 9 months, if 
there was marked deterioration of the ulcer with a 
rapid increase in size such that outpatient treatment 
could no longer be justified, or if over any 3 month 
period there was a failure of the ulcer to reduce in size. 
These patients were then considered for admission to 
hospital, bed rest and preparation for skin grafting. 
The pressures exerted under the bandages and 
dressings were measured using a Medical Stocking 
Tester (Salzman, St Gallen) with the patients both 
lying and standing. These pressures were assessed for 
eight patients in each group, with sub-bandage pres- 
sures being recorded at three sites: 2.5cm above the 
medial malleolus (P1), mid calf (P2), and upper calf 
(P3). 
The characteristics of the three groups were 
assessed by Chi-squared analysis for sex, and Kruskal- 
Wallis one way analysis of variance for other charac- 
teristics. Pressures beneath bandages were analysed 
using Kruskal-Wallis one way analysis of variance for 
unpaired ata, and Wilcoxon rank sum test for paired 
data. The time to healing was used as the dependent 
variable in a Cox regression analysis with the patient 
characteristics and the type of dressing considered as 
covariates. 
The rate of reduction of ulcer size in cm 2 per week 
was calculated for each patient for the time that they 
were in the study. This included patients who healed, 
those who did not heal and those who were with- 
drawn. The rate of reduction in ulcer size was 
compared for each group using a one way analysis of 
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variance with post hoc Bonferroni test to assess 
differences between groups. 
The sample size was assessed in order to provide an 
80% chance of detecting a 15% difference between the 
groups at the 5% level of significance. 
Results 
A total of 113 patients with 133 ulcerated limbs were 
entered into the study. The median age was 73 years 
with a range of 31-92 years. There were 67 females 
and 46 males entered into this study. Forty-three 
ulcerated limbs were randomised to Viscopaste, 46 to 
Kaltostat and 44 to Acoband. 
The characteristics of the patients in the three 
groups are shown in Table 1. The ulcer size data has 
been shown as both a mean and a median value, since 
other reports commonly use the mean value to 
represent he ulcer sizes of groups, however the 
median more accurately reflects the size of the ulcers 
in the study. There was no difference between the 
three treatment groups for any aspect of the ulcer 
history. This included uration of the current ulcer, the 
number of ulcer episodes on the affected limb, the 
time since the first episode of ulceration or the longest 
time that the patient had had an unhealed ulcer on the 
affected limb. There was a difference in the number of 
patients with superficial venous disease alone in the 
Table 1. Characteristics of the patients, history of ulceration and 
ulcer size in each group. 
Viscopaste Acoband Kaltostat 
Number of limbs 43 44 46 
Sex M:F 17:24 16:25 22:24 p=0.36 
Age (years) 
Median 73 76 70.5 p=0.36 
(Range) (33-89) (31-89) (36-92) 
Ulcer size (cm 2) 
Mean 10.11 9.14 11.02 p=0.20 
Median 3.60 2.94 4.57 
(Range) (0.15-57.46) (0.24-75.37) (0.36-61.32) 
Duration of current ulcer (months) 
Median 6.00 6.00 4.00 p=0.87 
(Range) (0.25-192) (0.25-5.04) (0.25-2.64) 
Number of ulcer episodes 
Median 2.0 2.0 3.0 p=0.38 
(Range) (1-23) (1-20) (1~t0) 
Longest ime with unhealed ulcer (months) 
Median 8 7 6 p=0.75 
(Range) (0.25-192) 0.5-504 0.25-264 
PPG 14:29 14:30 25:21 p<0.05 
(Superficial c.f. deep or communicating vein) 
Table 2. Pressures beneath different dressing treatments wit]" 
patients supine and erect, immediately after applying dressin~ 
and bandages (Median values mm Hg). 
After application 
Supine Erect 
Viscopaste P1 23 39 
P2 35 42 
P3 31 43 
Acoband P1 42 44 
P2 48 57 
P3 44 45 
Kaltostat P1 28 40 
P2 36 48 
P3 27 43 
Pl=2.5cm above medial malleolus; P2=mid calf; P3=upper calf. 
three treatment groups, with more limbs in the 
Kaltostat group (54%) having superficial venous dis- 
ease compared to those treated with Viscopaste (33%) 
and Acoband (32%). 
The pressures achieved under the different dressing 
methods are shown in Table 2. The pressures meas- 
ured after application of the dressings were sig- 
nificantly lower in the supine compared to the erect 
position (p < 0.01 for each measurement si e, Wilcoxon 
rank sum test). There was no difference between the 
three dressings in the erect position (p > 0.05 for each 
position, ANOVA). However, in the supine position 
there was a significant difference, and the highest 
pressures were recorded under Acoband and Elastoc- 
repe (p < 0.01 for each position, ANOVA). Due to the 
fragile nature of the probes, it was not possible to 
leave these in place for i week to enable assessment of 
pressures during the whole period for which the 
dressings and bandages were applied. 
A total of 21 limbs were withdrawn from the study 
for reasons unrelated to healing of the ulcer (Table 3). 
The number of patients with allergic reactions to each 
dressings were approximately the same. Three 
patients developed an intense, painful response to 
Kaltostat which ceased with removal of the Kaltostat. 
There was also one painful response with Viscopaste 
Table 3. Results of all ulcerated l imbs entered into the study. 
Viscopaste Acoband Kaltostat 
Withdrawals 
Allergy 2 1 1 
Pain 1 1 3 
Cellulitis 1 3 
Medical/Personal 2 3 3 
Completed trial 
Unhealed at 9 months 3 3 1 
Ulcer Deteriorated 1 9 9 
Ulcer Healed 34 26 26 
Total 43 44 46 
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and one with Acoband. Patients with cellulitis were 
withdrawn from the study and were admitted to 
hospital for treatment with intravenous antibiotics. 
The medical/personal reasons for withdrawal from 
the study included: admission to hospital with other 
medical problems (4), moving away from the city in 
which the study was performed (1), wrong dressing 
applied (2) and non-compliance with dressing (1). The 
patients who completed the trial therefore consisted of 
those who reached an end point of either healing, 
deterioration of ulceration requiring cessation of 
treatment or failure to heal with 9 months treatment. 
Viscopaste was clearly the most acceptable single 
treatment with 37/43 (86%) patients able to continue 
until healing or for 9 months compared to 29/44 (66%) 
for Acoband and 27/46 (59%) for Kaltostat. (Chi- 
squared = 8.43, p < 0.05). 
The influence on the time to healing of the patient 
variables and the different dressings are shown in 
Table 4. This clearly demonstrates that the type of 
dressing used, the initial size of the ulcer, and the side 
of the ulcerated limb all had a significant influence on 
the time to complete healing. Other parameters such 
as duration of the ulcer, the number of ulcer episodes, 
and the state of the deep veins did not have a 
significant impact on healing. 
The relative risks of healing for the limbs treated 
with Viscopaste compared with all limbs in the stud}4 
the limbs with smaller ulcers compared to larger 
ulcers (half ulcer area) and ulceration in the right leg 
compared to the left leg are shown in Table 5. These 
relative risks indicate that these limbs are 1.67, 1.96 
and 1.34 times more likely to heal. A life table showing 
the times to healing for the three different dressings is 
shown in Fig. 1 and clearly indicates the more rapid 
time to total limb healing seen in those patients treated 
with Viscopaste. 
The mean rate of reduction in ulcer size for each 
Table 4. Results of Cox regression analysis of influence of 
different variables on time to total limb healing. 
Coefficient S.E. p-Value 
Sex -0.1752 
Age 4),001 
Ulcer size ~),0336 
Ulcer duration 0,0013 
Number of ulcer episodes 0.0239 
Longest ime with unhealed ulcer -0,0032 
Time since first ulcer -0.0013 
PPG (Deep venous abn) -0.2664 
Limb 0.2582 
Dressing 
Viscopaste 0.5156 
Acoband -0.2678 
Kaltostat ~3.2478 
0.1174 0.14 
0.0086 0.92 
0.0102 0.001 
0.0068 0.85 
0.0231 0.30 
0.0053 O.54 
0.001 0.07 
0.2377 0.26 
0.1109 0.02 
0.1605 0.001 
0.1637 0.10 
0.1761 0.16 
Table 5. Odds ratio and confidence intervals for dressing, ulcer 
size and limb. 
95% Confidence Intervals 
Relative risk Lower Upper 
Viscopaste 1.67 1.24 2.24 
Size (half ulcer area) 1.96 1.55 2.47 
Limb (Right leg) 1.34 1.08 1.66 
group was 0.83cm2/week (C.I. 0.52-1.14) for Visco- 
paste, 0.53cm2/week (C.I. 0.17-0.89) for Acoband, and 
0.02cm2/week (C.I. -0.45-0.50) for Kaltostat. There 
was a significant difference in the rate of reduction in 
ulcer size for the groups (p <0.05). The post hoc 
Bonferroni test indicated a significant difference 
between the Viscopaste and Kaltostat reated groups 
(p<0.05), with no significant differences between 
other groups. 
Discussion 
This study clearly demonstrated that there was 
improved healing when a zinc oxide impregnated 
paste bandage was used under compression bandag- 
ing compared to the use of zinc oxide impregnated 
stockingette or a local alginate fibre dressing. This 
study evaluated healing as total healing of the limb, 
which is the only effective measure for evaluating 
treatments proposed as clinical treatment for venous 
ulcers. 
The rate of reduction in ulcer size did not clearly 
identify differences between the treatment groups that 
were more apparent when complete healing was 
assessed by Cox regression analysis. Analysis of 
complete healing identified Viscopaste treatment as a 
significant factor influencing the time to healing. 
However, analysis of the rate of reduction in ulcer size 
identified that the Viscopaste treated group healed 
faster than the Kaltostat group, but not the Acoband 
group. Clearly the measurement of time to healing 
allows multivariate analysis which may permit a more 
accurate determination of the effects of different 
treatments when considered in combination with 
other factors that influence ulcer healing. Assessment 
of rate of reduction in ulcer size does give some 
indication of differences between treatments, how- 
ever, this evaluation is not as sensitive as multivariate 
analysis. 
Clearly the topical zinc oxide did not directly 
influence ulcer healing when compared to an alginate 
dressing. Zinc oxide was present in both the zinc oxide 
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impregnated stockingette and the paste bandage, and 
the healing of the patients treated with the stock- 
ingette was slower than for a paste bandage, but no 
different o that of a locally applied dressing. 
The major difference would seem to be in the extra 
bandaging that the paste bandage mploys. The paste 
bandage consists of a zinc oxide impregnated non- 
stretch cotton bandage which differs from the Aco- 
band, which is zinc oxide impregnated stockingette. 
The sub-bandage pressures measured in the supine 
position were higher with Acoband which has some 
elasticity. However, there was no difference in the 
pressures measured in the erect position. The limita- 
tions of the measuring device prevented assessment of
pressures at the times when they are most likely to be 
different - -  throughout the week of application and 
during exercise. The implication of this study would 
be that on exercise the non-stretch bandage of Visco- 
paste imparts some added improvement in venous 
return in addition to that achieved by the compression 
bandaging. 
The times to healing using the zinc oxide bandage 
and compression bandaging were equivalent to those 
reported for the four layer system, ~6 with 64% of 
ulcers in this group healed at 12 weeks. The ulcers 
were also of a similar size when the mean values are 
compared. This is not a good descriptive statistic for 
ulcer size even though it has been used in many 
previous studies. Median area is a much better 
indicator of ulcer size in these patients. 
Further, from this study it is apparent that no single 
dressing is suitable in all patients. There are specific 
reasons why different dressings may not be used in 
individual patients. These are related mainly to 
allergy, pain caused by application of the dressing, 
and a failure of the ulcer to begin to heal. In this study, 
the single dressing that was most acceptable once 
appliedto the patients was the paste bandage. 
Many factors were considered in the analysis of this 
stud~ and we found that only ulcer size, ulceration on 
the right leg and the use of a paste bandage, had a 
significant impact on the time to healing of venous 
ulcers. Factors such as duration of ulceration, other 
features of the ulcer history, sex and age of the patient 
had no effect on the healing. This is in contrast o a 
previously reported study which suggested that ulcer 
duration, age of the patient and the extent of venous 
disease on PPG are significant factors in predicting the 
time to ulcer healing, is This difference may have 
occurred because the number of ulcerated limbs 
assessed in this study was smaller than that in the 
previously reported study (133 in this study compared 
to 20018), because of differences in the dressings and 
bandages used (Elastocrepe bandages and dressings 
in this study compared to Elastic stockings or double 
Tubigrip with local dressingslS), or because of the 
duration of the study period (9 months in this study 
compared to 4 months18). The influence of factors uch 
as age, ulcer duration and the extent of the venous 
disease may therefore only be significant predictors of 
ulcer healing when less effective methods of compres- 
sion or less accurate data on the time to ulcer 
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Fig. 1. Time to total imb healing in each treatment group in a life table. (--) Viscopaste; (--) Acoband (---) Kaltostat. 
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are used  in the  s tudy  des ign.  These  factors may not  be  
s ign i f icant  when opt ima l  compress ion  and  measures  
of  hea l ing  are used.  
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